ENTITY
Kalbe Farma

Kalbe Farma (KLBF IJ)

161
Analysis
Health CareIndonesia
PT Kalbe Farma Tbk produces and develops pharmaceutical products for human and animal healthcare. Through its subsidiaries, the Company also operates in the pharmaceutical, health food, and packaging industries.
more
12 Oct 2024 06:41Broker

Consumer: Sustained Solid Core Profit Growth on Stable Margins, in Line with Our and Consensus

We estimate 3Q24/9M24 sector revenue growth of +2.6%/+4% yoy and 9M24 operating profit of +7% yoy, in line with our and cons. est.

Logo
364 Views
Share
10 Oct 2024 18:37Broker

Consumer: 3Q24 Preview: Sustained Solid Core Profit Growth on Stable Margins

We estimate 3Q24/9M24 sector revenue growth of +2.6%/+4% yoy and 9M24 operating profit of +7% yoy, in line with our and cons. est.

Logo
239 Views
Share
28 Aug 2024 18:59Broker

Consumer: Sticking with the Winners Amid Lingering Challenges (OVERWEIGHT)

Amid continued downtrading and limited catalystsin 3Q24, we expect regional elections and social aid to support consumption spending.

Logo
197 Views
Share
09 Jul 2024 18:52Broker

Consumer: Expect Solid Core Profit Growth on Better Margins, Revenue Growth May Remain Soft

We estimate sector’s 2Q24 core profit to grow at a healthy doubledigit rate, but expect weak rev. growth (2.8% yoy/ -15.8% qoq)

Logo
172 Views
Share
09 Dec 2023 00:28Broker

Consumer: Room for Growth Is Still in Store (OVERWEIGHT)

We maintain our sector OW rating and expect ICBP (TP Rp13,000) and MYOR (TP Rp3,500) to fare better under a soft recovery scenario.

Logo
511 Views
Share
x